monsanto corp searle and unit said will report operating loss for 1987 mainly due expenses for research and development searle chairman sheldon gilgore said searle operating loss 1987 will less mln dlr operating loss 1986 said searle first quarter sales will pct 179 mln dlrs from 147 mln dlrs year ago quarter 1986 searle sales were 665 mln dlrs gilgore said company intends have sales three billion dlrs mid 1990s said company anticipates approval japan italy spain and for its ulcer treatment drug cytotech also said paper not yet published drug was prevent flare ulcers for longer period time tagamet made smithkline beckman corp drugs searle pipeline include tissue plasminogen activator tpa made different process genentech tpa expected approved for marketing this year reuter 